6Reuben A, Koch DG, Lee WM, et al. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology, 2010,52:2065-2076.
7Cohen DE, Anania FA, Chalasani N,et al. An assessment of statin safety by hepatologists. Am J Cardiol, 2006,97:77C-81C.
8McKenney JM, Davidson MH, Jacobson TA, et al. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol, 2006,97: 89C-94C.
9Poirier J. Apolipoprotein E and cholesterol metabolism in /he pathogenesis and treatment of Alzheimer's disease. Trends Mol Med, 2003, 9:94-101.
10Hoglund K, Thelen KM, Syversen S, et al. The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease. Dement Geriatr Cogn Disord,2005,19:256-265.
